期刊文献+

L-亮氨酸对干扰素粉雾剂性能的影响 被引量:6

Effects of L-Leucine on Properties of Interferon Dry Powder Inhalations
下载PDF
导出
摘要 考察了L-亮氨酸含量对以甘露醇或乳糖为主要赋形剂的载干扰素喷雾干燥颗粒的粒径、形态、吸湿性、流动性、分散性和胶囊中颗粒残留量等粉体学性质的影响,并进行了粉雾剂的体外沉积试验。结果表明,加入L-亮氨酸后,以甘露醇为赋形剂的颗粒压缩度大于乳糖颗粒,吸湿性和胶囊中颗粒残留量均小于乳糖颗粒。L-亮氨酸可提高两种粉雾剂的体外沉积量。 The effects of L-leucine content in the spray dried granules loaded with interferon α-2b using mannitol or lactose as main excipient on micromeritic properties, such as particle size, morphology, hygroscopicity, flowability, dispersibility and residual content of granules in capsule were investigated. The in vitro deposition of interferon dry powder inhalations was studied. The results showed that the compression degree of granules containing mannitol as excipient was greater than the one containing lactose after adding L-leucine in formulation, and hygroscopicity and residual content of the former were less than the latter. L-Leucine could improve the in vitro deposition of both dry powder inhalations.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2005年第12期747-750,共4页 Chinese Journal of Pharmaceuticals
关键词 L-亮氨酸 甘露醇 乳糖 干扰素Α-2B 体外沉积 粉雾剂 分散性 L-leucine mannitol lctose interferon α-2b in vitro deposition dry powder inhalation dispersibility
  • 相关文献

参考文献7

  • 1Perera AD, Kapitza C, Nosek L, et al. Absorption and metabolic effect of inhaled insulin: intrapatient variability after inhalation via the Aerodose insulin inhaler in patients with type 2 diabetes [J]. Diabetes Care, 2002, 25 (12) : 2276-2281.
  • 2Burnell PK, Small T, Doig S, et al. Ex-vivo product performance of Diskus and Turbuhaler inhalers using inhalation profiles from patients with severe chronic obstructive pulmonary disease[J]. Respir Med, 2001,95 (5) : 324-330.
  • 3Kokot M. Selection of a personal dry powder inhaler based on peak inspiratory flow measurements in selected groups of patients with bronchial obstruction [J]. Pol Merkuriusz Lek,2000, 9 (52) : 672-676.
  • 4Van't Veer NE, Lameijer W, De Ley M, et al. Teaching to inhale: better utilization of powder inhalators after counseling and instruction [J]. Ned Tijdschr Geneeskd, 2001, 145 (5):216-220.
  • 5Kamps AW, van Ewijk B, Roorda RJ, et al. Poor inhalation technique, even after inhalation instructions, in children with asthma [J]. Pediatr Pulmonol, 2000, 29 ( 1 ) : 39-42.
  • 6Harjunen P, Lankinen T, Salonen H, et al. Effects of carriers and storage of formulation on the lung deposition of a hydrophobic and hydrophilic drug from a DPI[J]. Int J Pharm,2003, 263(1-2): 151-163.
  • 7Bosquillon C, Lombry C, Preat V, et al. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance [J]. J Controlled Release, 2001, 70 (3) : 329-339.

同被引文献42

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部